Myanmar vs Spain: Previously treated cases tested for RR-/MDR-TB
Myanmar
94.0%
in 2024
Spain
94.0%
in 2024
Myanmar rank
72nd
Spain rank
72nd
Previously treated cases tested for RR-/MDR-TB over time
- Myanmar
- Spain
How they compare
Myanmar currently reports 94.0% against 94.0% in Spain, a difference of 0.0%.
The two have swapped places 2 times across 14 shared years of data; in 2006 it was Spain ahead.
Myanmar ranks 72nd and Spain ranks 72nd of 180 countries.
Across the 3 decades both report, Myanmar averaged higher in 2 and Spain in 1.
Head to head by decade
| Decade | Myanmar | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.9% | 49.0% | 40.1% | Spain |
| 2010s | 61.3% | 33.1% | 28.1% | Myanmar |
| 2020s | 92.8% | 74.5% | 18.2% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Myanmar or Spain?
- Myanmar, at 94.0% against 94.0% in Spain as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Myanmar and Spain?
- 0.0%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Spain?
- 14 years are reported by both, from 2006 to 2024.
- How do Myanmar and Spain rank globally for previously treated cases tested for rr-/mdr-tb?
- Myanmar ranks 72nd and Spain ranks 72nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.